Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Minimum Effective Dose (ED90) of Liposomal Bupivacaine for Preserving Motor Function After Interscalene Brachial Plexus Block: a Dose-finding Study

NCT06587386 is registered in ClinicalTrials.gov with Affiliated Hospital of Jiaxing University as lead sponsor.

NCT NCT06587386
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06587386 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Minimum Effective Dose (ED90) of Liposomal Bupivacaine for Preserving Motor Function After Interscalene Brachial Plexus Block: a Dose-finding Study
Lead sponsor
Affiliated Hospital of Jiaxing University
Phase
Phase 4
Overall status
Completed
Start date
May 20, 2025
Completion date
November 10, 2025
Enrollment
55 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

motion sickness